Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Antinuclear Antibody Positivity As a Risk Factor for Recurrent Pregnancy Loss: A Meta-Analysis
23 Pages Posted: 4 Jul 2019
More...Abstract
Background: Immunologic mechanisms have been one of the suggested causes of recurrent pregnancy loss (RPL). Antinuclear antibody positivity has been regarded as a typical feature of autoimmunity. Over past years many studies tried to clarify the association of ANA with RPL and the conclusions are controversial. The aim of this meta-analysis was to assess whether the presence of ANA directly increase the risk of RPL in women who did not have definite autoimmune diseases.
Methods: We searched PubMed and Embase databases for relevant literatures, which included the data of ANA rate in RPL and control groups. Both fixed-effects and randomized-effects model were used to analyze the risk odds ratio with 95% confidence intervals (CIs) according to the heterogeneity across the selected studies.
Findings: Twenty-one studies with 5038 participants including 2683 patients with RPL met the inclusion and exclusion criteria. The total positive rate of ANA was 22·4% (601/2683) in total RPL patients and 20·2% (397/1959) in unexplained RPL patients, respectively. Patients with total RPL or unexplained RPL had a significantly higher ANA positive rate than control groups [(OR =3·12, 95% CI:1·96, 4·97, I² = 77%), (OR = 3·47, 95% CI: 2·07, 5·81), I² = 74%], respectively]. Subgroup analysis demonstrated low titers of antibody (≤1: 80) were not associated with RPL patients [OR = 1·22, 95% CI (0·79, 1·90), I2 =86·1%], while higher ANA titer (≥1:160) showed a significant association between ANA and RPL patients [OR = 23·23, 95% CI (4·18,129·25, I 2 =0%)]. Higher rate of homogenous pattern in RPL group was observed [OR = 4·54, 95% CI (2·01, 10·24), I2=0%], and no significant difference in speckled pattern [OR = 1·08, 95% CI (0·69, 1·70), I 2 =0%] nor nucleolar pattern [OR = 3·52, 95% CI (0·93, 13·30), I 2 =0%] was found. Three studies detected the anti-dsDNA in two groups and the results demonstrated no significant difference between RPL group and controls [OR = 1·35, 95% CI (0·52, 3·54), I2=0%].
Interpretation: This is the first meta-analysis about the association between ANA positivity and RPL. The pooled data demonstrated increased prevalence of ANA in patients with RPL. ANA is suggested as a risk factor for RPL and should be recommended for this population.
Funding Statement: The work was supported by Natural Science Foundation of China (NSFC) Grant U1605223 to Dr. Guixiu Shi, NSFC grant 81501407 to Dr. Yuan Liu; NSFC grant 81501369 to Dr. Shiju Chen; and the Leadership Program of the Technology Department of Fujian Province (Grant NO. 2015D011) to Dr. Guixiu Shi.
Declaration of Interests: The authors declare no conflicts of interests.
Ethics Approval Statement: The meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
Keywords: Antinuclear antibody; Recurrent Pregnancy Loss; Risk factor; Meta-analysis
Suggested Citation: Suggested Citation